Loading...
Lexaria Bioscience Corp.
LEXXW•NASDAQ
Healthcare
Biotechnology
$0.11
$-0.11(-49.98%)
Lexaria Bioscience Corp. (LEXXW) Financial Performance & Statements
Review Lexaria Bioscience Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
105.24%
↑ 105.24%
Operating Income Growth
11.95%
↑ 11.95%
Net Income Growth
13.05%
↑ 13.05%
Operating Cash Flow Growth
15.68%
↑ 15.68%
Operating Margin
-1785.00%
↓ 1785.00%
Gross Margin
99.48%
↑ 99.48%
Net Profit Margin
-1784.18%
↓ 1784.18%
ROE
-107.00%
↓ 107.00%
ROIC
-136.94%
↓ 136.94%
Lexaria Bioscience Corp. (LEXXW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Lexaria Bioscience Corp. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $183923.00 | $84000.00 | $84000.00 | $145000.00 |
| Cost of Revenue | $2720.00 | $0.00 | $0.00 | $15931.00 |
| Gross Profit | $181203.00 | $84000.00 | $84000.00 | $129069.00 |
| Gross Profit Ratio | $0.99 | $1.00 | $1.00 | $0.89 |
| R&D Expenses | $1.95M | $967206.00 | $573089.00 | $245779.00 |
| SG&A Expenses | $918690.00 | $1.32M | $1.25M | $551295.00 |
| Operating Expenses | $2.87M | $2.29M | $1.83M | $797074.00 |
| Total Costs & Expenses | $2.87M | $2.29M | $1.83M | $813005.00 |
| Interest Income | $11.00 | $6993.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $1.00 |
| Depreciation & Amortization | $0.00 | -$7760.00 | $15074.00 | $15931.00 |
| EBITDA | -$2.69M | -$2.20M | -$1.73M | -$636801.00 |
| EBITDA Ratio | -$14.63 | -$26.23 | -$20.57 | -$4.50 |
| Operating Income | -$2.69M | -$2.20M | -$1.74M | -$668000.00 |
| Operating Income Ratio | -$14.63 | -$26.23 | -$20.75 | -$4.61 |
| Other Income/Expenses (Net) | -$12992.00 | $16493.00 | -$41393.00 | $15272.00 |
| Income Before Tax | -$2.70M | -$2.19M | -$1.78M | -$652733.00 |
| Income Before Tax Ratio | -$14.70 | -$26.03 | -$21.24 | -$4.50 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$3195.00 |
| Net Income | -$2.70M | -$2.18M | -$1.78M | -$649539.00 |
| Net Income Ratio | -$14.70 | -$26.009 | -$21.21 | -$4.48 |
| EPS | -$0.16 | -$0.17 | -$0.13 | -$0.06 |
| Diluted EPS | -$0.16 | -$0.17 | -$0.13 | -$0.06 |
| Weighted Avg Shares Outstanding | $16.67M | $13.12M | $13.86M | $10.77M |
| Weighted Avg Shares Outstanding (Diluted) | $16.67M | $13.12M | $13.86M | $10.77M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan